InfraReDx CEO To Discuss Vulnerable Plaque Identification With LipiScan(TM) Coronary

tD33NAt

Active member
Mar 24, 2008
12,519
0
36
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, announced that the Company's founder and chief executive officer, James E. Muller, M.D., will present and participate in a number of sessions and panel discussions during the annual Cardiovascular Research Technologies (CRT) 2010 meeting. CRT 2010, sponsored by Washington, D.C. based Washington Hospital Center, is being held February 21-23 at the city's Omni Shoreham Hotel. Dr...


jQAWybXuhO0


More...
 
Back
Top